Accessibility Menu
Chugai Pharmaceutical logo

Chugai Pharmaceutical(OTC) CHGCY

Current Price$21.87
Market Cap$71.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+616%
5 Year+28%
1 Year-8%
1 Month-5%
Chugai Pharmaceutical last closing stock price
MetricPriceDate
Last closeUSD 21.872026-07-24
Chugai Pharmaceutical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.27%USD 22.612026-07-17
1 month-4.87%USD 22.992026-06-24
3 month-19.65%USD 27.222026-04-24
Year to date-16.75%USD 26.272025-12-31
1 year-7.85%USD 23.732025-07-24
3 year+63.99%USD 13.342023-07-25
5 year+28.07%USD 17.082021-07-23
Since inception+616.46%USD 3.052010-11-23

Chugai Pharmaceutical Financials at a Glance

Market Cap

$71.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥1.36T

Net Income (TTM)

¥475.36B

EPS (TTM)

$0.93

P/E Ratio

24.03

Dividend

$0.46

Beta (Volatility)

0.53 (Low)

Price

$21.87

Volume

324,333

Open

$22.56

Previous Close

$21.87

Daily Range

$21.34 - $23.53

52-Week Range

$19.50 - $34.84

Estimated Earnings Date

Oct 23, 2026

CHGCY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in Tokyo, Japan, specializing in the research, development, manufacturing, and sale of innovative medicines. The company operates both domestically and internationally, with a strong presence in Europe, Taiwan, and China.

Products and Services
  • Innovative pharmaceuticals targeting oncology and autoimmune diseases
  • Research and development services for new drug formulations
  • Manufacturing and distribution of high-quality medicines
Growth Outlook
  • Recent quarterly revenue reached JPY 327.66 billion, indicating strong market demand
  • Net income for Q1 2026 was JPY 117.54 billion, showcasing profitability
  • Continued investment in R&D, with JPY 42.66 billion allocated in Q1 2026
Financial Highlights
  • Trailing twelve-month revenue of JPY 1.36 trillion, reflecting consistent growth
  • Net profit margin of 35.02% for the latest quarter, indicating operational efficiency
  • Strong cash position with JPY 419.80 billion in cash and equivalents as of Q1 2026
Chugai Pharmaceutical Co., Ltd. has established itself as a key player in the pharmaceutical industry, focusing on innovative solutions to address unmet medical needs. The company's robust financial performance, highlighted by a significant net income and strong revenue growth, positions it well for future expansion. With a commitment to research and development, Chugai is poised to continue delivering value to its stakeholders while contributing to advancements in healthcare.
AI Generated • Jun 29, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

7,872

CEO

Osamu Okuda

Website

www.chugai-pharm.co.jp

Headquarters

Chuo, SH 103-8324, JP

CHGCY Financials

Key Financial Metrics (TTM)

Gross Margin

71.39%

Operating Margin

47.24%

Net Income Margin

35.10%

Return on Equity

24.02%

Return on Capital

30.14%

Return on Assets

19.24%

Earnings Yield

4.16%

Dividend Yield

2.10%

Payout Ratio

94.94%

Stock Overview

Market Cap

$71.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.29B

Volume

324.33K

Avg. Volume

290.96K

Financials (TTM)

Gross Profit

¥970.13B

Operating Income

¥648.08B

EBITDA

¥699.55B

Operating Cash Flow

¥455.38B

Capital Expenditure

-¥68.19B

Free Cash Flow

¥387.19B

Cash & ST Invst.

¥853.78B

Total Debt

¥17.58B

Chugai Pharmaceutical Performance Analysis

Chugai Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31JPY 9,579,323,8285.3%
20232023-12-31JPY 7,903,733,267-17.5%
20242024-12-31JPY 7,727,065,222-2.2%
20252025-12-31JPY 8,408,723,7578.8%
Chugai Pharmaceutical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-300.5%
Q32025-09-3016.9%
Q42025-12-3118.4%
Q12026-03-31-18.4%
Chugai Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31JPY 0.873.2%
20232023-12-31JPY 0.70-18.7%
20242024-12-31JPY 0.7810.5%
20252025-12-31JPY 0.8813.5%
Chugai Pharmaceutical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-0.1%
Q32025-09-3016.9%
Q42025-12-3129.9%
Q12026-03-31-21.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

¥327.66B

+13.6%

Gross Profit

¥233.16B

+16.2%

Gross Margin

71.16%

N/A

Market Cap

$71.99BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$9.14M

N/A

Employees

7,872

N/A

Net Income

¥117.54B

+20.9%

EBITDA

¥174.62B

+27.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

¥853.78B

-9.6%

Total Debt

¥17.58B

+19990.2%

Accounts Receivable

¥354.47B

+20.3%

Inventory

¥289.54B

+24.2%

Long Term Debt

¥17.58B

N/A

Short Term Debt

¥0.00

N/A

Return on Assets

19.24%

N/A

Return on Invested Capital

30.83%

N/A

Free Cash Flow

¥112.74B

+152.9%

Operating Cash Flow

¥125.67B

+88.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SOAGYSartorius Aktiengesellschaft
$49.93-0.04%
MKGAFMerck KGaA
$159.92-0.12%
MKKGYMerck KGaA
$31.64-0.19%
IPSEYIpsen S.A.
$44.81-4.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About CHGCY

What is the current price of Chugai Pharmaceutical?

Chugai Pharmaceutical is trading at $21.87 per share.

What is the 52-week range for Chugai Pharmaceutical?

Over the past 52 weeks, Chugai Pharmaceutical has traded between $19.50 and $34.84.

How much debt does Chugai Pharmaceutical have?

As of the most recent reporting period, Chugai Pharmaceutical reported total debt of ¥110.04M.

How much cash does Chugai Pharmaceutical have on hand?

Chugai Pharmaceutical reported ¥2.40B in cash and cash equivalents in its most recent financial results.

What is Chugai Pharmaceutical’s dividend yield?

Chugai Pharmaceutical currently has a dividend yield of 2.10%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services